Tsuchimoto Kim R
Tsuchimoto Kim R, DIR, reported an open-market or private sale at Monopar Therapeutics involving 485.000000 shares for an estimated $52782.55. Reported holdings after the transaction were 3605.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 26, 2026
- Filing date
- Aug 29, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 4,090 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingMNPR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001437749-26-029235 Common Stock
- Transaction date
- Aug 26, 2026 Filed Aug 29, 2026, 12:18 AM · 3d delay
- Shares
- 485 sh $108.83 per share
- Estimated value
- -$52.7k Computed from shares × price
- Holdings after
- 3,605 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language. - amended_filing-6 points
is_amendment = true
Amended filing: the original transaction may have been restated.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026.
- F2
On August 28, 2018, the reporting person was granted stock options to purchase up to 8,220 shares of common stock. The options vest 6/51 on the six-month anniversary of vesting commencement date of Oc…
- F3
On February 2, 2022, the reporting person was granted stock options to purchase up to 16,279 shares of common stock. The options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.07 to $109.05, inclusive. The reporting person undertakes to pro…
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.07 to $110.04, inclusive. The reporting person undertakes to pro…
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.14 to $111.05, inclusive. The reporting person undertakes to pro…
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.30 to $112.27, inclusive. The reporting person undertakes to pro…
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.30 to $113.25, inclusive. The reporting person undertakes to pro…
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.35 to $114.34, inclusive. The reporting person undertakes to pro…
- F10
Represents shares held by the Kim R. Tsuchimoto Trust dated October 6, 2015.
0 other transactions
0 recent txs